Skip to main content
. Author manuscript; available in PMC: 2022 Aug 19.
Published in final edited form as: AIDS. 2020 Sep 1;34(11):1615–1623. doi: 10.1097/QAD.0000000000002615

Fig. 1.

Fig. 1.

Changes in biomarkers between the groups at baseline and 24 months. Graph showing median biomarkers with whiskers representing interquartile range, and the colored small dots are all values (a: soluble CD163, b: soluble CD14, c: IL-6, d: intestinal fatty acid binding protein, e: soluble tumor necrosis factor receptor a II, f: oxidized LDL, g: high sensitivity C-reactive protein) in youth living with perinatally acquired HIV and HIV at enrollment and 24 months. Biomarkers were log transformed. Wilcoxon test used, P values represent differences between youth living with perinatally acquired HIV and HIV at each time point. hsCRP, high sensitivity C-reactive protein; IFAB-P, intestinal fatty acid binding protein; IL-6, interleukin 6; sCD14 and 163, soluble CD14 and 163; sTNFRII, soluble tumor necrosis factor receptor a II.